The BTA stat test: a tumor marker for the detection of upper tract transitional cell carcinoma
Authors:
- Patrick F KeanePKPatrick F Keane
- Laura M IshakLILaura M Ishak
- Karen A FlesslandKFKaren A Flessland
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- HUMAN COMPLEMENT FACTOR H RELATED PROTEIN TEST FOR MONITORING BLADDER CANCERJournal of Urology, 2001
- Mechanistic Studies of the Effects of Anti-factor H Antibodies on Complement-mediated LysisJournal of Biological Chemistry, 2000
- COMPARISON OF MOLECULAR AND CONVENTIONAL STRATEGIES FOR FOLLOWUP OF SUPERFICIAL BLADDER CANCER USING DECISION ANALYSISJournal of Urology, 2000
- UPPER TRACT RECURRENCES FOLLOWING RADICAL CYSTECTOMY: AN ANALYSIS OF PROGNOSTIC FACTORS, RECURRENCE PATTERN AND STAGE AT PRESENTATIONJournal of Urology, 1999
- NONINVASIVE DETECTION OF BLADDER CANCER WITH THE BTA STAT TESTJournal of Urology, 1999
- Comparison of the BTA statTM Test with Voided Urine Cytology and Bladder Wash Cytology in the Diagnosis and Monitoring of Bladder CancerEuropean Urology, 1999
- Specificity of Human Complement Factor H-Related Protein Test (Bard BTA stat Test)Scandinavian Journal of Urology and Nephrology, 1999
- Improved detection of recurrent bladder cancer using the bard bta stat testUrology, 1997
- The Risk of Upper Tract Recurrence Following Cystectomy in Patients with Transitional Cell Carcinoma Involving the Distal UreterJournal of Urology, 1996
- Upper Tract Tumours following Cystectomy for Bladder Cancer. Is Routine Intravenous Urography Worthwhile?British Journal of Urology, 1991